v3.26.1
Consolidated Interim Statements of Cash Flows (Unaudited) - CAD ($)
 3 Months Ended
Mar. 31, 2026
Mar. 31, 2025
Operating activities:    
Loss for the period $ (908,660) $ (10,677,419)
Items not involving cash:    
Finance expense 680
Share-based compensation 663,252
Depreciation 654 1,074
Loss from revaluation of settlement agreement (191,884) 128,100
Change in benefits to employees 3,456 918
Loss from revaluation of warrants 7,314,179
Unrealized foreign exchange loss (gain) (563) 16,042
Changes in non-cash working capital items:    
Trade receivables 567 (3,578)
Other receivables 473,290 129,587
Trade payables and accrued liabilities (11,819) 174,199
Inventory (7,888)
Deferred revenue (36,378) (26,368)
Prepaid expenses 30,781 (58,983)
Related parties (13,607) (68,187)
Net cash used in operating activities (662,051) (2,406,504)
Investing activities:    
Purchase of property and equipment (1,760) (1,300)
Investment accounted for using the equity method (801,493)
Net cash used in investing activities (803,253) (1,300)
Financing activities:    
Proceeds from public offering, net 20,734,691
Repayment of long-term loan (14,112)
Net cash provided by financing activities 20,720,579
Net Increase (decrease) in cash (1,465,304) 18,312,775
Effect of foreign exchange rate changes on cash 235,371 31,949
Cash at beginning of period 15,231,108 4,617,034
Cash at end of period 14,001,175 22,961,758
Supplemental disclosure of cash flow information    
Cash paid during the period for interest $ 680